The final products of this genes targets p53 and RB (of the most important genes controlling cellular processes) and could disrupt the cell cycle, transformation initiation, and finally tumor development (Doorbar, 2006; Khodabandehlou, 2019). The gene discussed is RB1; the disease is neoplasm.